Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic

Journal of Visceral Surgery

Volumn 157, Issue 3, 2020, Pages S7-S12

  Tuech, J J ^a,b   Gangloff, A ^a   Di Fiore, F ^a,b   Michel, P ^a,b   Brigand, C ^c   Slim, K ^d   Pocard, M ^e,f   Schwarz, L ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cancer; Coronavirus; Covid 19; Digestive surgery; Surgical complications

Indexed keywords

CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DIGESTIVE SYSTEM DISEASE; DIGESTIVE SYSTEM TUMOR; HEALTH SERVICE; HUMAN; LAPAROSCOPY; PANDEMIC; POSTOPERATIVE CARE; PRACTICE GUIDELINE; TIME TO TREATMENT; VIRUS PNEUMONIA;

CORONAVIRUS INFECTIONS; DIGESTIVE SYSTEM DISEASES; DIGESTIVE SYSTEM NEOPLASMS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LAPAROSCOPY; PANDEMICS; PNEUMONIA, VIRAL; POSTOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; TIME-TO-TREATMENT;

EID: 85082816874     PISSN: 18787886     EISSN: 18787878     Source Type: Journal    
DOI: 10.1016/j.jviscsurg.2020.03.008     Document Type: Article

References (21)

1. Liang, W., Guan, W., Chen, R., et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21:3 (2020), 335–337.
2. Zhang, Y., Xu, J.M., [Medical diagnosis and treatment strategies for malignant tumors of the digestive system during the outbreak of novel coronavirus pneumonia]. Zhonghua Zhong Liu Za Zhi, 42(0), 2020, E005.
3. Chen, Y.H., Peng, J.S., [Treatment strategy for gastrointestinal tumor under the outbreak of novel coronavirus pneumonia in China]. Zhonghua Wei Chang Wai Ke Za Zhi 23:2 (2020), I–IV.
4. Hu, X.H., Niu, W.B., Zhang, J.F., et al. [Thinking of treatment strategies for colorectal cancer patients in tumor hospitals under the background of coronavirus pneumonia]. Zhonghua Wei Chang Wai Ke Za Zhi, 23(3), 2020, E002.
5. Wu, F., Song, Y., Zeng, H.Y., et al. [Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of novel coronavirus pneumonia]. Zhonghua Zhong Liu Za Zhi, 42(0), 2020, E004.
6. Alves, A., Panis, Y., Mathieu, P., et al. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study. Arch Surg 140:3 (2005), 278–283 [discussion 84].
7. Denost, Q., Rouanet, P., Faucheron, J.L., et al. To Drain or Not to Drain Infraperitoneal Anastomosis After Rectal Excision for Cancer: The GRECCAR 5 Randomized Trial. Ann Surg 265:3 (2017), 474–480.
8. Lefevre, J.H., Mineur, L., Kotti, S., et al. Effect of Interval (7 or 11 weeks) Between Neoadjuvant Chemoradiotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized Controlled Trial (GRECCAR-6). J Clin Oncol 34:31 (2016), 3773–3780.
9. Habr-Gama, A., Perez, R.O., Sabbaga, J., Nadalin, W., Sao Juliao, G.P., Gama-Rodrigues, J., Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period. Dis Colon Rectum 52:12 (2009), 1927–1934.
10. El Amrani, M., Lenne, X., Clement, G., et al. Specificity of Procedure volume and its Association With Postoperative Mortality in Digestive Cancer Surgery: A Nationwide Study of 225,752 Patients. Ann Surg 270:5 (2019), 775–782.
11. Schwarz, L., Bruno, M., Parker, N.H., et al. Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy. Ann Surg Oncol 22:11 (2015), 3522–3529.
12. Mirkin, K.A., Hollenbeak, C.S., Wong, J., Time to Surgery: a Misguided Quality Metric in Early Stage Pancreatic Cancer. J Gastrointest Surg 22:8 (2018), 1365–1375.
13. Swords, D.S., Zhang, C., Presson, A.P., Firpo, M.A., Mulvihill, S.J., Scaife, C.L., Association of time-to-surgery with outcomes in clinical stage I-II pancreatic adenocarcinoma treated with upfront surgery. Surgery 163:4 (2018), 753–760.
14. Mariette, C., Markar, S., Dabakuyo-Yonli, T.S., et al. Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label. Randomized Phase III Controlled Trial: The MIRO Trial. Ann Surg, 2019.
15. Bartlett, E.K., Roses, R.E., Kelz, R.R., Drebin, J.A., Fraker, D.L., Karakousis, G.C., Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database. Surgery 156:2 (2014), 298–304.
16. Wang, W.J., Li, R., Guo, C.A., et al. Systematic assessment of complications after robotic-assisted total versus distal gastrectomy for advanced gastric cancer: A retrospective propensity score-matched study using Clavien-Dindo classification. Int J Surg 71 (2019), 140–148.
17. Fujiya, K., Irino, T., Furukawa, K., et al. Safety of prolonged wait time for gastrectomy in clinical stage I gastric cancer. Eur J Surg Oncol 45:10 (2019), 1964–1968.
18. Oh, S.Y., Lee, J.H., Lee, H.J., et al. Natural History of Gastric Cancer: Observational Study of Gastric Cancer Patients Not Treated During Follow-Up. Ann Surg Oncol 26:9 (2019), 2905–2911.
19. Kawaguchi, Y., Fuks, D., Kokudo, N., Gayet, B., Difficulty of Laparoscopic Liver Resection: Proposal for a New Classification. Ann Surg 267:1 (2018), 13–17.
20. Hobeika, C., Fuks, D., Cauchy, F., et al. Impact of cirrhosis in patients undergoing laparoscopic liver resection in a nationwide multicentre survey. Br J Surg 107:3 (2020), 268–277.
21. An, C., Choi, Y.A., Choi, D., et al. Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease. Clin Mol Hepatol 21:3 (2015), 279–286.